Astrazeneca (AZN) Dips More Than Broader Markets: What You Should KnowZacks Investment Research • 12/18/21
Citi recommends buy of AstraZeneca on the back of Evusheld announcementProactive Investors • 12/17/21
Citi recommends BUY of AstraZeneca stock on the back of Evusheld announcementProactive Investors • 12/17/21
AstraZeneca says anti-body combination offers 'neutralising activity' against OmicronProactive Investors • 12/17/21
Transgene announces License Option Exercise by AstraZeneca for an Oncolytic Virus Generated by Transgene's Invir.IO™ PlatformBusiness Wire • 12/15/21
ENHERTU® Additional Analyses Further Reinforce Groundbreaking Efficacy in Patients with HER2 Positive Metastatic Breast CancerBusiness Wire • 12/09/21
AstraZeneca's COVID-19 Therapy Wins FDA Approval As First Antibody To Prevent Infection In ImmunocompromisedBenzinga • 12/09/21
FDA authorizes AstraZeneca's monoclonal antibodies for some who can't get vaccinated or are immunocompromisedMarket Watch • 12/08/21
Mix & Match Pfizer, AstraZeneca COVID-19 Vaccine With Moderna Shows Improved Immune ResponseBenzinga • 12/07/21
Datopotamab Deruxtecan Continues to Show Promising Durable Response and Disease Control in Patients with Metastatic Triple Negative Breast CancerBusiness Wire • 12/07/21
Ionis, AstraZeneca Ink Licensing Pact For Eplontersen In Protein Misfolding DisorderBenzinga • 12/07/21
AstraZeneca's takeover of Alexion the highlight of a quieter quarter for mergers & acquisitionsProactive Investors • 12/07/21
AstraZeneca agrees licensing deal with California biotech worth up to US$3.5bnProactive Investors • 12/07/21
Could Moderna and AstraZeneca's mRNA Heart Failure Drug Candidate Be a Winner?The Motley Fool • 12/04/21
AstraZeneca Reinforces Leadership in Breast Cancer at SABCS 2021 With New Data Underscoring Ambition to Redefine Cancer CareBusiness Wire • 12/03/21